Medicenna Therapeutics to join two investor conferences in February 2025

financialpost.com

Medicenna Therapeutics will participate in two investor conferences in February 2025. The events will include a presentation on February 11 and a fireside chat on February 28 in New York City. The company will also hold one-on-one meetings with investors during these conferences. Medicenna focuses on developing Superkines for cancer and autoimmune diseases, with ongoing clinical trials for its therapies.


With a significance score of 1.6, this news ranks in the top 30% of today's 26796 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Medicenna Therapeutics to join two investor conferences in February 2025 | News Minimalist